Jacobs Levy Equity Management
UPB

Jacobs Levy Equity Management’s Upstream Bio Inc UPB Stock Holding History

Jacobs Levy Equity Management’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
+253,092
New +$2.12M 0.01% 623

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jacobs Levy Equity Management's UPB Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 253,092 shares worth $1.75M. The stake represents 0.01% of the portfolio and ranks #623 among its holdings.

150 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Jacobs Levy Equity Management held 253,092 shares of Upstream Bio Inc worth $1.75M as of Q2 2026.
  • Upstream Bio Inc was a new Jacobs Levy Equity Management position in Q2 2026.
  • Upstream Bio Inc made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #623 holding.
  • 150 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.